Skip to main content
SpringerLink
Log in

Optimal therapy for small noncleaved cell lymphoma

  • Chapter
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems

Part of the book series: Cancer Treatment and Research ((CTAR,volume 66))

Abstract

Small noncleaved lymphoma (SNCL) is a high grade diffuse lymphoma. It has also been known as diffuse undifferentiated lymphoma, and according to the Working Formulation for non-Hodgkin’s lymphoma is subdivided into Burkitt’s and non-Burkitt’s types [1]. While occurring infrequently relative to other non-Hodgkin’s lymphomas, SNCL is of particular interest because it is a model of a biologically aggressive, yet curable neoplasm [2–4]. If patients with this lymphoma receive no treatment or ineffective treatment, they die rapidly, with a median survival measured in months. Small noncleaved cell lymphoma occurs most frequently in children and has been best studied in this group. However, several recent series have reported the clinical features and results of treatment in adults with SNCL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. The Non-Hodgkin’s Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of non-Hodgkin’s lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112, 1982.

    Google Scholar 

  2. Ziegler JL, Deissroth AB, Applebaum FR, et al.: Burkitt’s lymphoma — a model for intensive chemotherapy. Semin Oncol 4:317–323, 1977.

    PubMed  CAS  Google Scholar 

  3. Sullivan MP, Ramirez J: Curability of Burkitt’s lymphoma with high-dose cyclophosphamide, high dose methotrexate therapy and intrathecal chemoprophylaxis. J Clin Oncol 3:626–636, 1985.

    Google Scholar 

  4. Magrath IT, Janus C, Edwards BK, et al.: An effective therapy for both undifferentiated (including Burkitt’s) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 63:1102–1111, 1984.

    PubMed  CAS  Google Scholar 

  5. Burkitt DP: The discovery of Burkitt’s lymphoma. Cancer 51:1777–1786, 1983.

    Article  PubMed  CAS  Google Scholar 

  6. Sarna GP, Kagan AR: Small non-cleaved cell lymphoma (Burkitt’s and non-Burkitt’s types). In CM Haskell, ed. Cancer Treatment. Philadelphia: WB Saunders, 1990, pp 725–732.

    Google Scholar 

  7. Miliauskas MB, Berard CW, Young RC, et al.: Undifferentiated non-Hodgkin’s lymphoma (Burkitt’s and non-Burkitt’s types). The relevance of making this histologic distinction. Cancer 50:2115–2121, 1982.

    CAS  Google Scholar 

  8. Levine AM, Pavlova Z, Pachras AW: Small non-cleaved follicular center cell (FCC) lymphoma: Burkitt’s and non-Burkitt’s variants in the United States. I. Clinical features. Cancer 52:1073–1079, 1983.

    Article  PubMed  CAS  Google Scholar 

  9. Levine AM: Non-Hodgkin’s lymphomas and other malignancies in the acquired immune deficiency syndrome. Semin Oncol 14(Suppl 3):34–39, 1987.

    PubMed  CAS  Google Scholar 

  10. Ziegler JC, Bechstead JA, Valberding PA, et al.: Non-Hodgkin’s lymphoma in 90 homosexual men. N Engl J Med 311:565–570, 1984.

    Article  PubMed  CAS  Google Scholar 

  11. Knowles DM, Cahamarlak GA, Subar M, et al.: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 108:744–753, 1988.

    PubMed  CAS  Google Scholar 

  12. Lukes RJ, Collins RD: Lukes-Collins classification and its significance. Cancer Treat Rep 61:971, 1977.

    PubMed  CAS  Google Scholar 

  13. Pavlova Z, Parker JW, Taylor CR, et al.: Small non-cleaved follicular center cell lymphoma: Burkitt’s and non-Burkitt’s variants in the U.S. Cancer 59:1982, 1987.

    Article  Google Scholar 

  14. Bernheim A, Berger R: Cytogenetic studies of Burkitt’s lymphoma-leukemia in patients with acquired immune deficiency syndrome. Cancer Genet Cytogenet 32:67, 1988.

    Article  PubMed  CAS  Google Scholar 

  15. Subar M, Neri A, Inghwanui G, et al.: Frequent C-MYC oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 72:667–671, 1988.

    PubMed  CAS  Google Scholar 

  16. Burkitt D: Long-term remissions following one and two-dose chemotherapy for African lymphoma. Cancer 20:756–759, 1967.

    Article  PubMed  CAS  Google Scholar 

  17. Burkitt D, Hutt MSR, Wright DH: The African lymphoma: preliminary observations on response to therapy. Cancer 18:399–410, 1965.

    Article  PubMed  CAS  Google Scholar 

  18. Oettgen HF, Murphy ML: Malignant lymphoma of childhood in the United States and Burkitt’s tumour in Africa: therapeutic results. In JH Burchenal, DP Burkitt, eds. Treatment of Burkitt’s Tumour. New York: Springer, 1967, pp 105–108.

    Google Scholar 

  19. Sullivan M: NHL of childhood. In WW Sutow, TJ Vieti, D Fernbach, eds. Clinical Pediatric Oncology, St. Louis: Mosby, 1977, pp 452–497.

    Google Scholar 

  20. Cohen MH, Bennett JM, Berard CW, et al.: Burkitt’s tumor in the United States. Cancer 23:1259–1272, 1969.

    Article  PubMed  CAS  Google Scholar 

  21. Wallner N, Burchenal JH, Leiberman PH, et al.: Non-Hodgkin’s lymphoma in children. Med Pediatr Oncol 1:235, 1975.

    Article  Google Scholar 

  22. Anderson JR, Wilson JF, Jenkins DT: Childhood non-Hodgkin’s lymphoma: results of a randomized therapeutic trial comparing a 4 drug regimen (COMP) to a 10 drug regimen (LSA2-L2). N Engl J Med 308:559, 1983.

    Article  PubMed  CAS  Google Scholar 

  23. Djerassi I, Kim JS: Methotrexate and citrovorum factor rescue in the management of childhood lymphosarcoma and reticulum cell sarcoma (non-Hodgkin’s lymphomas): prolonged unmaintained remissions. Cancer 38:1043–1051, 1976.

    Article  PubMed  CAS  Google Scholar 

  24. Hutchison RE, Murphy SB, Fairclough DL, et al.: Diffuse small noncleaved cell lymphoma in children, Burkitt’s versus non-Burkitt’s types. Cancer 64:23–28, 1989.

    Article  PubMed  CAS  Google Scholar 

  25. Kaufmann BH, Burgert EO, Banks PM: Abdominal Burkitt’s lymphoma: role of early aggressive surgery. J Pediatr Surg 22:671–674, 1987.

    Article  Google Scholar 

  26. Murphy SB, Bowman WP, Abromowitch M, et al.: Results of treatment of advanced-stage Burkitt’s lymphoma and B cell (Slgt) acute lymphablastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 4:1732–1739, 1986.

    PubMed  CAS  Google Scholar 

  27. Oviatt DC, Cousar JB, Flexner JM, et al.: Malignant lymphoma of follicular center cell origin in humans: IV. Small transformed (noncleaved) cell lymphoma of the non-Burkitt’s type. Cancer 1196–1201, 1983.

    Google Scholar 

  28. Gragan TM, Warnke RA, Haplan HS: A comparative study of Burkitt’s and non-Burkitt’s “undifferentiated” malignant lymphoma. Cancer 49:1817–1828, 1982.

    Article  Google Scholar 

  29. Sharin AT, Canellos GP, Rosenthal DS, et al.: Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol 1:91, 1983.

    Google Scholar 

  30. Conners JM, Klimo P: MACOP-B chemotherapy for malignant lymphomas and related conditions: 1987 update and additional observations. Semin Hematol 25:41, 1988.

    Google Scholar 

  31. Fisher RI, DeVita VT, Hubbard SM, et al.: Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of PRO-MACE and MOPP chemotherapy. Ann Intern Med 98:304, 1983.

    PubMed  CAS  Google Scholar 

  32. Longo DC, DeVita VT, Duffey PL, et al.: Superiority of Pro-MACE CytaBOM over PRO-MACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. J Clin Oncol 9:25, 1991.

    PubMed  CAS  Google Scholar 

  33. Bernstein JI, Coleman CN, Strickler JG, et al.: Combined modality therapy for adults with small non-cleaved cell lymphoma (Burkitt’s and non-Burkitt’s types). J Clin Oncol 4:847, 1986.

    PubMed  CAS  Google Scholar 

  34. Herbrecht R, Coiffier B, Bosley A, et al.: Small noncleaved cell lymphomas: clinical study of 39 cases treated with LNH-84 regimen. Proc Am Soc Clin Oncol 8:261, 1989.

    Google Scholar 

  35. Lopez TM, Hagemeister FB, McLaughlin P, et al.: Small non-cleaved cell lymphoma in adults: superior results for Stages I—III disease. J Clin Oncol 8:615, 1990.

    PubMed  CAS  Google Scholar 

  36. McMaster ML, Greer JP, Greco FA, et al.: Effective treatment of small noncleaved cell lymphoma with high-intensity, brief duration chemotherapy. J Clin Oncol 9:941–946, 1991.

    PubMed  CAS  Google Scholar 

  37. Mashal RD, Canellos GP: Small non-cleaved cell lymphoma in adults. Am J Hematol 38:40–47, 1991.

    Article  PubMed  CAS  Google Scholar 

  38. Longo DC, Glatstein E, Duffey PL, et al.: Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. J Clin Oncol 7:1295, 1989.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. R. Dean Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John D. Hainsworth
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oregon Health Sciences University, USA

    Bruce W. Dana (Clinical Associate Professor of Medicine, Member) (Clinical Associate Professor of Medicine, Member)

  2. The Hematology Clinic Portland, Oregon, USA

    Bruce W. Dana (Clinical Associate Professor of Medicine, Member) (Clinical Associate Professor of Medicine, Member)

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Butler, R.D., Hainsworth, J.D. (1993). Optimal therapy for small noncleaved cell lymphoma. In: Dana, B.W. (eds) Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems. Cancer Treatment and Research, vol 66. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3084-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3084-8_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6347-7

  • Online ISBN: 978-1-4615-3084-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation